The role of oxidized HDL in monocyte/macrophage functions in the pathogenesis of atherosclerosis in Rhesus monkeys

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 59, Issue 3, 1999, Pages 215-225

  Sharma, N ^a   Desigan, B ^a   Ghosh, S ^a   Sanyal, S N ^b   Ganguly, N K ^a   Majumdar, S ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b PANJAB UNIVERSITY   (India)

Author keywords

Antioxidant enzyme; Atherosclerosis; Cholesterol efflux; Monocyte functions; Oxidized HDL

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ANIMAL EXPERIMENT; AORTA ATHEROSCLEROSIS; AORTA MEDIA; ARTICLE; ATHEROGENESIS; LIPID PEROXIDATION; LIPID TRANSPORT; MACROPHAGE; MALE; MONOCYTE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; RHESUS MONKEY; VASCULAR ENDOTHELIUM;

EID: 0033039227     PISSN: 00365513     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365519950185742     Document Type: Article

References (42)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1993; 362: 801-9.
2. Kitamura A, Iso H, Naito Y, Iida M, Konishi M, Folson AR, Satio S, Kiyama M, Nakamura M, Sankai T, Shimamoto T, Komachi Y. High density lipoprotein cholesterol and premature coronary heart disease in urban Japanese men. Circulation 1994; 89: 2533-7.
3. Jacobs Dr Jr, Mebane IL, Bangdiwala SI, Griqui MW, Tyroler HA. High density lipoprotein cholesterol as a predictor of Cardiovascular disease. Mortality in men and women: the follow up study of the lipid research clinics: prevalance study. Am J Epidemol 1990; 131: 32-47.
4. Chakravarti RN, Firshenbaum LA, Singal RK. Atherosclerosis: its pathophysiology with special reference to lipid peroxidation. J Appl Cardiol 1991; 6: 91-112.
5. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 1984; 48: 323-40.
6. Brown MS, Goldstein JL. Lipoprotein receptors in the liver: control signals for plasma cholesterol traffic. J Clin Invest 1983; 72: 743-7.
7. Rothblat GH, Mahlberg FM, Johnson WJ, Phillips MC. Apolipoproteins, membrane cholesterol domains, and the regulation of cholesterol efflux. J Lipid Res 1992; 33: 1091-7.
8. Parthasarathy S, Rankin SH. Role of oxidised low density lipoprotein in atherogenesis. Prog Lipid Res 1992; 31: 127-33.
9. Rubin EM, Krauss RM, Spangler EA, Verstufft JG, Chift SM. Inhibition of early atherogenesis in transgenic mice by human apoprotein A-I. Nature 1991; 353: 265-8.
10. Parthasarathy S, Barnett J, Fong LG. High density lipoprotein inhibits the oxidative modification of low density lipoprotein. Biochim Biophys 1990; 1049: 275-83.
11. Maier JAM, Barenghi L, Pagani F, Bradamante S, Comi R, Ragnotti G. The protective role of high density lipoprotein or oxidised low density lipoprotein induced U937/endothelial cell interactions. Eur J Biochem 1994; 221: 35-41.
12. Babiy AV, Gabicki JM, Sullivan DR. Vitamin E content and low density lipoprotein oxidizability induced by free radicals. Atherosclerosis 1990; 81: 175-82.
13. Nishigaki I, Hagihara M, Tsunekawa H, Maseki M, Yagi K. Lipid peroxide levels of serum lipoprotein fractions diabetic patients. Biochem Med 1991; 25: 373-8.
14. Nagano Y, Hidenori A, Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci USA 1991; 88: 6457-62.
15. Ghiselli G, Giorgini L, Gelati M, Musanti R. Oxidatively modified HDLs are potent inhibitors of cholesterol biosynthesis in human skin fibroblasts. Arteriosclerosis Thromb 1992; 12: 929-34.
16. Chung BH, Thomas W, Geer JC, Jere PS. Preparative and quantitative isolation of plasmalipoproteins, rapid single discontinuous density gradient ultracentrifugation in the vertical rotor J Lipid Res 1980; 21: 284-90
17. Zak B. Simple rapid microtechnique of serum total cholesterol. J Clin Pathol 1959; 27: 583-8.
18. Esterbauer H, Striegl G, Puhl H, Rotherdrm. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Rad Res Comm 1989; 6: 67-75.
19. Okhawa H, Oshishi N, Yagi H. Reaction of linoleic and hydroperoxide with TBA. J Lipid Res 1979; 19: 1053-7.
20. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Invest 1968; 21: 77-89.
21. Doershuk PE, Bowen-Rop DF. Cultured endothelial cells produce a platelet derived growth factor like protein. Proc Natl Acad Sci USA 1983; 80: 1919-24.
22. Yarm LT, Li CY, Crosky WH. Cytochemical identification monocytes and granulocytes. Am J Clin Pathol 1971; 55: 283-90.
23. Bilheimer DW, Eisenberg S, Levy RJ. The metabolism of VLDL proteins. Preliminary in vitro and in vivo observations. Biochim Biophys Acta 1972; 260: 212-8.
24. Goldstein JL, Basu SF, Brown MG. Receptor mediated endocytosis of low density lipoprotein in cultured cells. Methods in Enzymology 1986; 98: 241-61.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. J Biol Chem 1951; 193: 265-75.
26. Kilsdonk EPC, Vangent T, Vantol A. Characterization of human high density lipoprotein subclass LPA-I and LPA-I/A-II and binding to Hep-G2 cells. Biochim Biophys Acta 1992: 205-12.
27. Kono Y. Generation of superoxide radical during auto oxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochem Biophys 1978; 186: 189-95.
28. Luck H. Catalase. In: Bergmeyer HW, editor. Methods of enzymatic analysis. New York: Academic Press, 1963; 3: 885-94.
29. Paglia DE, Valentine WM. Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1987; 70: 158-69.
30. Doershuk CM, Alar MF, Hogg JF. Neutrophill kinetics in rabbits during infusion of zymosan activated plasma. J Appl Physiol 1989; 65: 88-95.
31. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site of macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition. Proc Natl Acad Sci USA 1979; 76: 333-7.
32. Laville AE, Sola R, Balanya J, Turner PR, Masana L. In vitro oxidised HDL is recognised by the scavenger receptor of macrophages: implications for its protective role in vivo. Atherosclerosis 1994: 179-89.
33. Regnstrom J, Walladius G, Hadell K, Johnsson J, Holme I, Olsson AG, Neilsson J. Influence of lipoprotein, lipids, dietary fat and smoking on macrophage degradation of native and oxidized low density lipoprotein. Atherosclerosis 1994; 110: 13-23.
34. Mackness MI, Arrol S, Durrington PN. Protection of low density lipoprotein against oxidative modification by high density lipoprotein associated paraoxonase. Atherosclerosis 1993; 104: 129-35.
35. Miller NE, Forde OH, Thelle DS, Mjos OD. The Tromso Heart Study, high density lipoprotein and coronary heart disease: a prospective case control Study. Lancet 1977; 1: 965-7.
36. Sakai M, Mujazaki A, Sakamoto YI, Sohichiri M, Hotiuschi S. Cross linking of apolipoproteins is involved in a loss of the ligand activity of high density lipoprotein upon Ca2+ mediated oxidation. FEBS Lett 1992; 314: 199-204.
37. Fruchart JC, Geteire CD, Delfly D, Castro GR. Apolipoprotein A-I containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis risk. Atherosclerosis 1994; 1: S35-9.
38. Morel DW, Dicarleto PE, Chisolm GM. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 1984; 4: 357-64.
39. Oram JF, Albers JJ, Cheung MC, Bierman EL. The effects of subfraction of high densitylipoprotein on cholesterol efflux from fibroblasts. Regulation of low density lipoprotein receptor activity. J Biol Chem 1981; 256: 8348-56.
40. Sattler W, Maiorino M, Stocker R. Reduction of HDL and LDL associated cholesteryl ester and phospholipid hydroperoxides by phospholipid hydroperoxide glutathione peroxidase and Ebselen (P 251). Arch Biochem Biophys 1994; 1309: 214-21.
41. Klimov AN, Gurevich VS, Nikiforova AA, Shatilina LV, Kazin AA, Planvinski SL, Teryukava NP. Antioxidative activity of high density lipoproteins in vivo. Atherosclerosis 1993; 100: 13-8.
42. Cockerill GW, Rye KA, Gamble JR, Vadas MA, Barter PJ. High density lipoprotein inhibit cytokine induced expression of endothelial cell adhesion molecules. Arterioscler Thromb Vasc Biol 1995; 15: 1987-94.